2022 Headache Medicine Reading List, Learning Objectives, and CME

Reading List

Please click below to access the 2022 Headache Medicine reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Describe the imaging findings of both intracranial hypertension and spontaneous intracranial hypotension
• Describe the clinical features of new daily persistent headache and tension-type headache
• Assemble a list of medications with established benefit in the acute treatment of migraine headaches
• Describe several relevant drug-drug interactions associated with the use of acute and preventive migraine medications

Core Competencies

• Medical Knowledge

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2022 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Headache Medicine Certification Examination Committee Contributors

Jerry W. Swanson, MD, Chair, Mayo Clinic – Rochester
Disclosures: Receives royalty payments from UpToDate for editorial services; serves as speaker for MER at CPD meetings.

Robert G. Kaniecki, MD, Vice Chair, University of Pittsburgh Medical Center
Disclosures: Nothing to disclose.

Randolph W. Evans, MD, Baylor College of Medicine
Disclosures: Receives speaker fees for being member of speaker's bureaus for Allergan, Amgen, Biohaven, Impel, and Teva; serves as consultant for Lundbeck.

P. Christopher H. Gottschalk, MD, Yale Neurology – Headache Division
Disclosures: Receives fees as a consultant for Alder/Lundbeck Biopharmaceuticals and Upsher-Smith; provides consulting services to Spherix Global Insights, a marketing research firm; serves as board member of HCNE (Headache Cooperative of New England).

Christopher B. Oakley, MD, Johns Hopkins University – Department of Child Neurology
Disclosures: Nothing to disclose.

Lauren D. Strauss, DO, Wake Forest Baptist Health
Disclosures: Nothing to disclose.

Jelena M. Pavlovic, MD, PhD, Montefiore Headache Center
Disclosures: Receives compensation for serving as speaker/panelist for Neurology Live and for Biohaven. Serves on advisory board for Abbvie.

Thomas Berk, MD, NYU Langone Health
Disclosures: Receives compensation as Neura Health Medical Director; received research support from Amgen for employee wellness initiative. Serves as PI for clinical trials for Theranica and Lunbeck.

Debra G. Davis, MD, LSU Health – Shreveport
Disclosures: Nothing to disclose.

Stephanie J. Nahas, MD, Thomas Jefferson University/Jefferson Headache Center
Disclosures: Received honoraria for consulting from Allergan/AbbVie, Amgen/Novartis, Biohaven, Ely Lilly, Nesos Corp (formerly Vorso Corp), Teva; received honoraria for speaking from Allergan/AbbVie, Amgen/Novartis, Ely Lilly, Teva; received honoraria for work in education or publishing from American Academy of Neurology, American Headache Society, Evolve Med Ed, MedLink Neurology, MJH Life Sciences, Neurology Learning Network, Pennsylvania Neurologic Society, Springer, WebMD, and Wolters-Kluwer; received legal fees for serving as a medical expert to Jackson & Campbell. Teva provided a grant for research for chart review studies which supported 1-2% of effort for less than 1 year.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326